bis-Pyridinium cyclophanes: novel ligands with high affinity for the blood-brain barrier choline transporter.
A series of bis-pyridinium cyclophane analogs designed as conformationally restricted bis-quaternary ammonium compounds were evaluated for their affinity for the blood-brain barrier (BBB) choline transporter. All the cyclophanes investigated exhibited high affinity compared to choline. Of these compounds, N, N'-(1,10-decanediyl)3,3'-(1,9-decadiyn-1,10-diyl)-bis-pyridinium diiodide (5c) and N,N'-(1,9-nonanediyl)3,3'-(1,9-decadiyn-1,10-diyl)-bis-pyridinium dibromide (5b) exhibited highest affinity with K(i) values of 0.8 microM and 1.4 microM, respectively, and constitute some of the most potent BBB choline transporter ligands reported.
Zhang
Zhenfa
Z
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
Lockman
Paul R
PR
Mittapalli
Rajendar K
RK
Allen
David D
DD
Dwoskin
Linda P
LP
Crooks
Peter A
PA
D001692:Biological Transport; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001952:Bridged-Ring Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D002794:Choline / Q000737:chemistry; D015195:Drug Design; D006801:Humans; D007700:Kinetics; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D026901:Membrane Transport Proteins / Q000737:chemistry* / Q000378:metabolism; D008956:Models, Chemical; D008968:Molecular Conformation; D011725:Pyridines / Q000737:chemistry*; D011726:Pyridinium Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000737:chemistry
D001952:Bridged-Ring Compounds; D008024:Ligands; D026901:Membrane Transport Proteins; D011725:Pyridines; D011726:Pyridinium Compounds; D000644:Quaternary Ammonium Compounds; C065637:choline transporter; D002794:Choline; C023666:pyridine
Neuropharmacology. 2007 Mar;52(3):755-63
17097117
Adv Exp Med Biol. 1993;331:83-93
8333351
Bioorg Med Chem Lett. 2004 Apr 19;14(8):1863-7
15050617
Biochem Biophys Res Commun. 1994 May 16;200(3):1762-8
8185636
Br J Pharmacol. 2008 Feb;153(4):792-804
18059317
J Pharmacol Exp Ther. 2003 Mar;304(3):1268-74
12604705
J Pharmacol Exp Ther. 2002 Jun;301(3):1088-96
12023541
Bioorg Med Chem Lett. 2004 Jun 21;14(12):3085-92
15149650
J Pharmacol Exp Ther. 2008 Jan;324(1):244-50
17921191
J Pharmacol Exp Ther. 2008 Aug;326(2):563-76
18460644
AAPS J. 2005 Aug 29;7(1):E201-17
16146341
J Pharmacol Exp Ther. 2003 Jan;304(1):400-10
12490617
Curr Med Chem. 2004 Jun;11(12):1617-28
15180567
Neuropharmacology. 2008 Jun;54(8):1189-200
18448138
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6701-6
17977723
J Neurochem. 2001 Feb;76(4):1032-41
11181822
Clin Pharmacokinet. 2007;46(7):553-76
17596102
Life Sci. 2003 Aug 15;73(13):1609-15
12875893
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6734-8
18029180
Pharmacol Ther. 1980;8(2):237-74
6992155
Nat Rev Drug Discov. 2002 Feb;1(2):131-9
12120094
J Neurochem. 2003 Aug;86(3):627-34
12859676
Bioorg Med Chem Lett. 2004 Apr 19;14(8):1869-74
15050618
Psychopharmacology (Berl). 2006 Mar;184(3-4):426-34
16220336
Bioorg Med Chem. 2005 Jul 1;13(13):4253-61
15878282
Drug Dev Ind Pharm. 2002 Aug;28(7):749-71
12236062
Cancer Res. 1992 Apr 15;52(8):2191-6
1559223
Pharm Res. 2007 Sep;24(9):1745-58
17619998